PAHO Health Core Indicators

Core Indicators dataset download

This dataset contains Health Core Indicators from the Americas region from 1995 to the latest available year.

Hide used fields

Fields used in the database

FieldDescription
paho_indicator_idPAHO ID for this indicator
indicator_nameName of the indicator in english
nombre_indicadorName of the indicator in spanish
spatial_dim_typeType of spatial dimension
spatial_dimValue of the spatial dimension (iso code)
spatial_dim_enName of the spatial dimension in english
spatial_dim_esName of the spatial dimension in spanish
time_dim_typeType of temporal dimension
time_dimValue of the temporal dimension
numeric_valueNumeric value of this data
value_as_stringValue of this data as a string
lowLower value for this data (Estimation)
highHigher value for this data (Estimation)
technical_noteTechnical note in english
nota_tecnicaTechnical note in spanish
data_source_typeType of data source
data_source_specificSpecific value of the data source
data_provider_typeType of data provider
data_provider_specificSpecific value of the data provider
data_secondary_source   Secondary data source
type_statisticsType of statistics
public_privatePublic or private sector in english
public_private_spPublic or private sector in spanish
source_urlURL of the source
preliminaryMark for preliminary data
published_atDate of publication at the source
accessed_atDate of accessed by PAHO

Hide list of indicators

List of Indicators included in the dataset

  1. Adolescent fertility rate (births per 1 000 women aged 15-19 years)
  2. Alzheimer disease and other dementias mortality rate (age-adjusted per 100 000 pop)
  3. Alzheimer disease and other dementias mortality rate (age-adjusted per 100 000 pop); female
  4. Alzheimer disease and other dementias mortality rate (age-adjusted per 100 000 pop); male
  5. Annual GDP growth (%)
  6. Annual parasite incidence (1 000 pop)
  7. Annual population growth rate (%)
  8. Antenatal care coverage -at least 4 visits (%)
  9. Births (thousands)
  10. Births attended by skilled health personnel (%)
  11. Breast cancer incidence rate (age-adjusted per 100 000 pop); female
  12. Breast cancer mortality rate (age-adjusted per 100 000 pop); female
  13. Cervical cancer incidence rate (age-adjusted per 100 000 pop); female
  14. Cervical cancer mortality rate (age-adjusted per 100 000 pop); female
  15. Children under age 5 who are wasted (weight for height) (%)
  16. Cholera cases
  17. Circulatory diseases mortality rate (age-adjusted per 100 000 pop)
  18. Circulatory diseases mortality rate (age-adjusted per 100 000 pop); female
  19. Circulatory diseases mortality rate (age-adjusted per 100 000 pop); male
  20. Cirrhosis mortality rate (age-adjusted per 100 000 pop)
  21. Cirrhosis mortality rate (age-adjusted per 100 000 pop); female
  22. Cirrhosis mortality rate (age-adjusted per 100 000 pop); male
  23. Colorectal cancer mortality rate (age-adjusted per 100 000 pop)
  24. Colorectal cancer mortality rate (age-adjusted per 100 000 pop); female
  25. Colorectal cancer mortality rate (age-adjusted per 100 000 pop); male
  26. Communicable diseases mortality rate (age-adjusted per 100 000 pop)
  27. Communicable diseases mortality rate (age-adjusted per 100 000 pop); female
  28. Communicable diseases mortality rate (age-adjusted per 100 000 pop); male
  29. Concentration of fine particulate matter (PM2.5); cities
  30. Contraceptive prevalence use, modern methods (%)
  31. Contraceptive prevalence use; modern methods (%); married or in union women
  32. Contraceptive prevalence use; modern methods (%); unmarried women
  33. Corpus uteri cancer mortality rate (age-adjusted per 100 000 pop); female
  34. Crude birth rate (1 000 pop)
  35. Crude death rate (1 000 pop)
  36. Deaths (thousands)
  37. Deaths due to tetanus in children under age 5
  38. Deaths due to tetanus neonatorum
  39. Deaths from communicable diseases (%)
  40. Deaths from communicable diseases (%); female
  41. Deaths from communicable diseases (%); male
  42. Deaths from measles
  43. Deaths from noncommunicable diseases (%)
  44. Deaths from noncommunicable diseases (%); female
  45. Deaths from noncommunicable diseases (%); male
  46. Deaths from pertussis in children under age 5
  47. Deaths in children under age 5 due to diphtheria
  48. Demand for family planning satisfied by any modern method (%)
  49. Demand for family planning satisfied by any modern method (%); married or in union women
  50. Demand for family planning satisfied by any modern method (%); unmarried women
  51. Dengue cases
  52. Density of Dentists (10 000 pop) [new]
  53. Density of Medical Doctors (10 000 pop) [new]
  54. Density of Midwives (10 000 pop) [new]
  55. Density of Pharmacists (10 000 pop) [new]
  56. Dependency ratio (100 pop)
  57. Diabetes mellitus mortality rate (age-adjusted per 100 000 pop)
  58. Diabetes mellitus mortality rate (age-adjusted per 100 000 pop); female
  59. Diabetes mellitus mortality rate (age-adjusted per 100 000 pop); male
  60. Diphtheria cases in children under age 5
  61. DMFT index at age 12
  62. Estimated infant mortality rate (1 000 lb)
  63. Estimated maternal mortality ratio (100 000 lb)
  64. Estimated under-five mortality (1 000 lb)
  65. Exclusive breastfeeding under 6 months (%)
  66. External causes mortality rate (age-adjusted per 100 000 pop)
  67. External causes mortality rate (age-adjusted per 100 000 pop); female
  68. External causes mortality rate (age-adjusted per 100 000 pop); male
  69. Falls mortality rate (age-adjusted per 100 000 pop)
  70. Falls mortality rate (age-adjusted per 100 000 pop); female
  71. Falls mortality rate (age-adjusted per 100 000 pop); male
  72. General mortality rate (age-adjusted per 1 000 pop)
  73. General mortality rate (age-adjusted per 1 000 pop); female
  74. General mortality rate (age-adjusted per 1 000 pop); male
  75. GINI Index
  76. Gross domestic product (US$ per capita), current international (PPP-adjusted)
  77. Gross national income (US$ per capita), current international (PPP-adjusted)
  78. Gross national income per capita, Atlas method (current US$)
  79. HIV/AIDS mortality rate (age-adjusted per 100 000 pop)
  80. HIV/AIDS mortality rate (age-adjusted per 100 000 pop); female
  81. HIV/AIDS mortality rate (age-adjusted per 100 000 pop); male
  82. Homicide mortality rate (age-adjusted per 100 000 pop)
  83. Homicide mortality rate (age-adjusted per 100 000 pop); female
  84. Homicide mortality rate (age-adjusted per 100 000 pop); male
  85. Hospital beds ratio (1 000 pop)
  86. Hospital ICU beds ratio (100 000 pop)
  87. Human rabies cases
  88. Human rabies cases; female
  89. Human rabies cases; male
  90. Ill-defined and unknown causes of death (%)
  91. Immunization coverage (%), PCV3
  92. Immunization coverage of 1 year old (%), MMR1
  93. Immunization coverage of under-1 year old (%), BCG
  94. Immunization coverage of under-1 year old (%), DTP3-cv
  95. Immunization coverage of under-1 year old (%), Polio 3
  96. Immunization coverage of under-1 year old (%), Rotavirus
  97. Incidence of congenital syphilis (1 000 live births)
  98. Infant deaths
  99. Infant mortality rate (1 000 lb)
  100. Inflation (%)
  101. Injury deaths (%)
  102. Injury deaths (%); female
  103. Injury deaths (%); male
  104. Ischemic heart diseases mortality rate (age-adjusted per 100 000 pop)
  105. Ischemic heart diseases mortality rate (age-adjusted per 100 000 pop); female
  106. Ischemic heart diseases mortality rate (age-adjusted per 100 000 pop); male
  107. Kuznets ratio
  108. Leprosy cases in treatment
  109. Leptospirosis cases
  110. Leptospirosis cases; female
  111. Leptospirosis cases; male
  112. Life expectancy at birth (years)
  113. Life expectancy at birth (years); female
  114. Life expectancy at birth (years); male
  115. Low birthweight (<2 500 g) (%)
  116. Lower respiratory infection mortality rate (age-adjusted per 100 000 pop)
  117. Lower respiratory infection mortality rate (age-adjusted per 100 000 pop); female
  118. Lower respiratory infection mortality rate (age-adjusted per 100 000 pop); male
  119. Lung cancer incidence rate (age-adjusted per 100 000 pop)
  120. Lung cancer incidence rate (age-adjusted per 100 000 pop); female
  121. Lung cancer incidence rate (age-adjusted per 100 000 pop); male
  122. Lung cancer mortality rate (age-adjusted per 100 000 pop)
  123. Lung cancer mortality rate (age-adjusted per 100 000 pop); female
  124. Lung cancer mortality rate (age-adjusted per 100 000 pop); male
  125. Malaria cases
  126. Malignant neoplasms mortality rate (age-adjusted per 100 000 pop)
  127. Malignant neoplasms mortality rate (age-adjusted per 100 000 pop); female
  128. Malignant neoplasms mortality rate (age-adjusted per 100 000 pop); male
  129. Maternal deaths
  130. Maternal mortality ratio (100 000 lb)
  131. Mean years of schooling (years)
  132. Mean years of schooling (years); female
  133. Mean years of schooling (years); male
  134. Measles cases
  135. Median age (years)
  136. Mortality attributable to household and ambient air pollution (age-adjusted per 100 000 pop)
  137. Mortality attributable to household and ambient air pollution (age-adjusted per 100 000 pop); female
  138. Mortality attributable to household and ambient air pollution (age-adjusted per 100 000 pop); male
  139. Mortality garbage codes (%)
  140. Mortality under-registration (%)
  141. Municipalities with DTP3 coverage >= 95%
  142. Neonatal deaths
  143. Neonatal mortality rate (1 000 lb)
  144. New HIV diagnoses rate (100 000 pop)
  145. New HIV diagnoses rate (100 000 pop); female
  146. New HIV diagnoses rate (100 000 pop); male
  147. New HIV diagnoses; sex ratio (male:female)
  148. Noncommunicable diseases mortality rate (age-adjusted per 100 000 pop)
  149. Noncommunicable diseases mortality rate (age-adjusted per 100 000 pop); female
  150. Noncommunicable diseases mortality rate (age-adjusted per 100 000 pop); male
  151. Nursing personnel density (10 000 pop) [new]
  152. Out-of-pocket expenditure as % of current health expenditure
  153. Pancreas cancer mortality rate (age-adjusted per 100 000 pop)
  154. Pancreas cancer mortality rate (age-adjusted per 100 000 pop); female
  155. Pancreas cancer mortality rate (age-adjusted per 100 000 pop); male
  156. Pertussis cases in children under age 5
  157. Population aged < 15 years (%)
  158. Population aged < 15 years (%); female
  159. Population aged < 15 years (%); male
  160. Population aged < 15 years (thousands)
  161. Population aged < 15 years (thousands); female
  162. Population aged < 15 years (thousands); male
  163. Population aged < 5 years (thousands)
  164. Population aged < 5 years (thousands); female
  165. Population aged < 5 years (thousands); male
  166. Population aged 15 and over (thousands)
  167. Population aged 15 and over (thousands); female
  168. Population aged 15 and over (thousands); male
  169. Population aged 20 and over (thousands)
  170. Population aged 20 and over (thousands); female
  171. Population aged 20 and over (thousands); male
  172. Population aged 65 and over (%)
  173. Population aged 65 and over (%); female
  174. Population aged 65 and over (%); male
  175. Population aged 65 and over (thousands)
  176. Population aged 65 and over (thousands); female
  177. Population aged 65 and over (thousands); male
  178. Population at risk of malaria (%)
  179. Population using clean fuels and technology (%)
  180. Population using clean fuels and technology (%); rural
  181. Population using clean fuels and technology (%); urban
  182. Population using improved sanitation facilities; safely managed (%)
  183. Population using improved sanitation facilities; safely managed (%); rural
  184. Population using improved sanitation facilities; safely managed (%); urban
  185. Population using improved water supplies; safely managed (%)
  186. Population using improved water supplies; safely managed (%); rural
  187. Population using improved water supplies; safely managed (%); urban
  188. Postneonatal mortality rate (1 000 lb)
  189. Poverty headcount ratio at $ 2.15 day (2017 PPP) (% of population)
  190. Poverty headcount ratio at national poverty line (% of population)
  191. Prevalence of anemia in women of reproductive age
  192. Prevalence of children under age 5 who are stunted (%)
  193. Prevalence of current tobacco use in adolescents (%)
  194. Prevalence of current tobacco use in adolescents (%); female
  195. Prevalence of current tobacco use in adolescents (%); male
  196. Prevalence of current tobacco use in adults (%)
  197. Prevalence of current tobacco use in adults (%); female
  198. Prevalence of current tobacco use in adults (%); male
  199. Prevalence of insufficient physical activity in adolescents (%)
  200. Prevalence of insufficient physical activity in adolescents (%); female
  201. Prevalence of insufficient physical activity in adolescents (%); male
  202. Prevalence of insufficient physical activity in adults (%)
  203. Prevalence of insufficient physical activity in adults (%); female
  204. Prevalence of insufficient physical activity in adults (%); male
  205. Prevalence of obesity in children/adolescents aged 10-19 years (%)
  206. Prevalence of obesity in children/adolescents aged 10-19 years (%); female
  207. Prevalence of obesity in children/adolescents aged 10-19 years (%); male
  208. Prevalence of overweight and obesity in adults (%)
  209. Prevalence of overweight and obesity in adults (%); female
  210. Prevalence of overweight and obesity in adults (%); male
  211. Prevalence of overweight in children under age 5 (%)
  212. Prevalence of raised blood glucose/diabetes in adults (%)
  213. Prevalence of raised blood glucose/diabetes in adults(%); female
  214. Prevalence of raised blood glucose/diabetes in adults(%); male
  215. Prevalence of raised blood pressure in adults (%)
  216. Prevalence of raised blood pressure in adults (%); female
  217. Prevalence of raised blood pressure in adults (%); male
  218. Private health expenditure as % of GDP
  219. Proportion of births attended at health facilities (%)
  220. Proportion of population with HIV who receive ART
  221. Proportion of voluntary non remunerated blood donation (%)
  222. Prostate cancer mortality rate (age-adjusted per 100 000 pop); male
  223. Public health expenditure as % of GDP
  224. Respiratory diseases mortality rate (age-adjusted per 100 000 pop)
  225. Respiratory diseases mortality rate (age-adjusted per 100 000 pop); female
  226. Respiratory diseases mortality rate (age-adjusted per 100 000 pop); male
  227. Road injury mortality rate (age-adjusted per 100 000 pop)
  228. Road injury mortality rate (age-adjusted per 100 000 pop); female
  229. Road injury mortality rate (age-adjusted per 100 000 pop); male
  230. Stomach cancer incidence rate (age-adjusted per 100 000 pop)
  231. Stomach cancer incidence rate (age-adjusted per 100 000 pop); female
  232. Stomach cancer incidence rate (age-adjusted per 100 000 pop); male
  233. Stomach cancer mortality rate (age-adjusted per 100 000 pop)
  234. Stomach cancer mortality rate (age-adjusted per 100 000 pop); female
  235. Stomach cancer mortality rate (age-adjusted per 100 000 pop); male
  236. Stroke diseases mortality rate (age-adjusted per 100 000 pop)
  237. Stroke diseases mortality rate (age-adjusted per 100 000 pop); female
  238. Stroke diseases mortality rate (age-adjusted per 100 000 pop); male
  239. Suicide mortality rate (age-adjusted per 100 000 pop)
  240. Suicide mortality rate (age-adjusted per 100 000 pop); female
  241. Suicide mortality rate (age-adjusted per 100 000 pop); male
  242. Tetanus neonatorum cases
  243. Total alcohol per capita (age 15+ years) consumption
  244. Total alcohol per capita (age 15+ years) consumption; female
  245. Total alcohol per capita (age 15+ years) consumption; male
  246. Total fertility rate (live births per woman)
  247. Total population (thousands) 0-1 years
  248. Total population (thousands) 0-1 years; female
  249. Total population (thousands) 0-1 years; male
  250. Total population (thousands) 1-4 years
  251. Total population (thousands) 1-4 years; female
  252. Total population (thousands) 1-4 years; male
  253. Total population (thousands) 10-19 years
  254. Total population (thousands) 10-19 years; female
  255. Total population (thousands) 10-19 years; male
  256. Total population (thousands) 15-24 years
  257. Total population (thousands) 15-24 years; female
  258. Total population (thousands) 15-24 years; male
  259. Total population (thousands) 15-49 years; female
  260. Total population (thousands) 15-64 years
  261. Total population (thousands) 25-44 years
  262. Total population (thousands) 25-44 years; female
  263. Total population (thousands) 25-44 years; male
  264. Total population (thousands) 45-64 years
  265. Total population (thousands) 45-64 years; female
  266. Total population (thousands) 45-64 years; male
  267. Total population (thousands) 5-14 years
  268. Total population (thousands) 5-14 years; female
  269. Total population (thousands) 5-14 years; male
  270. Total population (thousands) 65-74 years
  271. Total population (thousands) 65-74 years; female
  272. Total population (thousands) 65-74 years; male
  273. Total population (thousands) 75+ years
  274. Total population (thousands) 75+ years; female
  275. Total population (thousands) 75+ years; male
  276. Tuberculosis incidence rate (100 000 pop)
  277. Tuberculosis mortality rate (age-adjusted per 100 000 pop)
  278. Tuberculosis mortality rate (age-adjusted per 100 000 pop); female
  279. Tuberculosis mortality rate (age-adjusted per 100 000 pop); male
  280. Under age 5 deaths due to acute respiratory infections (%)
  281. Under age 5 deaths due to infectious intestinal disease (%)
  282. Under-five mortality (1 000 lb)
  283. Unemployment rate (%)
  284. Unemployment rate (%); female
  285. Unemployment rate (%); male
  286. Unintentional poisoning mortality rate (age-adjusted per 100 000 pop)
  287. Unintentional poisoning mortality rate (age-adjusted per 100 000 pop); female
  288. Unintentional poisoning mortality rate (age-adjusted per 100 000 pop); male
  289. Urban Population (%)
  290. Wild poliomyelities cases
  291. Women accessing prenatal care since the first trimester (%)
  292. Yellow fever cases
  293. Youth literacy rate (%)
  294. Youth literacy rate; female
  295. Youth literacy rate; male

 

Download all data
(ZIP 4.3Mb [CSV 92Mb])
Apr. 19th, 2024

For more information about the indicators, please visit Technical specifications and latest updates.

Suggested citation: Pan American Health Organization/World Health Organization. Core Indicators Portal. Region of the Americas. Washington D.C. [Consulted: DATE]. Available from: https://opendata.paho.org/en/core-indicators